Alternatives to carbapenems in ESBL-producing Escherichia coli infections
Pierre‐Edouard Fournier(Méditerranée Infection Foundation), Xavier Bertrand(Centre National de la Recherche Scientifique), Catherine Chirouze(Centre Hospitalier Universitaire de Besançon), Pascal Cholley(Centre Hospitalier Universitaire de Besançon), J. Leroy(Centre Hospitalier Universitaire de Besançon), Patrick Plésiat(Hôpital Ambroise-Paré), D. Talon(Centre National de la Recherche Scientifique)
Cited by 61
Related Papers
Pseudomonas aeruginosa: resistance and therapeutic options at the turn of the new millennium
|Clinical Microbiology and Infection|2007|575
Endemicity, molecular diversity and colonisation routes of Pseudomonas aeruginosa in intensive care units
|Intensive Care Medicine|2001|189
Wastewater Treatment Plants Release Large Amounts of Extended-Spectrum β-Lactamase–Producing Escherichia coli Into the Environment
|Clinical Infectious Diseases|2014|172
Pseudomonas aeruginosa: antibiotic susceptibility and genotypic characterization of strains isolated in the intensive care unit
|Clinical Microbiology and Infection|2001|169
The role of the hospital environment in the epidemiology of multi-resistant bacteria
|Journal of Hospital Infection|1999|130